ZP General Partner 3 ApS: Financial statements 2021
CVR: 41023422
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
ZP General Partner 3 ApS (CVR 41023422) has filed annual accounts for 2021. In 2021, the company reported a gross profit of USD 0 and a net result of USD -1,000 compared with USD 218,000 the year before. Equity in the 2021 report amounted to USD 7,000. The solvency ratio was 8.6%.
- Revenue
- USD 0
- Gross Profit
- USD 0
- Profit/Loss
- USD -1,000
- Equity
- USD 7,000
- Total Assets
- USD 81,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 USD | 0 USD | -1K USD | 7K USD | - |
| 2020 | 280K USD | -279K USD | 218K USD | 245K USD | - |
Official annual report
Find more companies like ZP General Partner 3 ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
ZP General Partner 3 ApS has published its annual report for 2020. Revenue came to DKK 280,000, and the net result was DKK 218,000.
As of June 30, 2021, EY Godkendt Revisionspartnerselskab has been appointed auditor of ZP General Partner 3 ApS.
As of June 29, 2021, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ZP General Partner 3 ApS.
About ZP General Partner 3 ApS
ZP General Partner 3 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The company is owned by ZEALAND PHARMA A/S. In 2025, the company reported revenue of DKK 1,000 and a net result of DKK -29,000 compared with DKK -18,000 the year before. Equity in the 2025 report amounted to DKK 30,000.